AI-based drug developer Basecamp valued at $800 million after $140 million funding round
Direct Source Verification:
This story is aggregated from Reuters (reuters.com). Full reporting rights and copyright belong to the primary publisher.
AI-based drug developer Basecamp valued at $800 million after $140 million funding round Reuters
Original Source
https://www.reuters.com/legal/litigation/ai-based-drug-developer-basecamp-valued-800-million-after-140-million-funding-2026-09-23/
